|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| A61P 7/02 | (2006.01) | ||
| A61P 9/10 | (2006.01) |
| (11) | Number of the document | 1493745 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04015299.3 |
| Date of filing the European patent application | 2001-05-31 | |
| (97) | Date of publication of the European application | 2005-01-05 |
| (45) | Date of publication and mention of the grant of the patent | 2012-04-25 |
| (46) | Date of publication of the claims translation | 2012-07-25 |
| (30) | Number | Date | Country code |
| 0013407 | 2000-06-02 | GB |
| (72) |
Bohlin, Martin, SE
Cosgrove, Steve, GB
Lassen, Bo, SE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Nauja triazol(4,5-D)pirimidino junginio kristalinė ir amorfinė forma |
| New crystalline and amorphous form of a triazolo(4,5-D)pyrimidine compound |
| Payment date | Validity (years) | Amount | |
| 2020-04-23 | 347.00 EUR |